User profiles for Thomas Rawson

Thomas Rawson

Imperial College London
Verified email at imperial.ac.uk
Cited by 377

Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells

GL James, JL Goldstein, MS Brown, TE Rawson… - Science, 1993 - science.org
Oncogenic Ras proteins transform animal cells to a malignant phenotype only when
modified by farnesyl residues attached to cysteines near their carboxyl termini. The …

Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study

…, N Imai, PN Perez-Guzman, ES Knock, T Rawson… - The Lancet, 2021 - thelancet.com
Background England's COVID-19 roadmap out of lockdown policy set out the timeline and
conditions for the stepwise lifting of non-pharmaceutical interventions (NPIs) as vaccination …

A class of 2, 4-bisanilinopyrimidine Aurora A inhibitors with unusually high selectivity against Aurora B

…, J Moffat, G Phillips, R Pulk, TE Rawson… - Journal of medicinal …, 2009 - ACS Publications
The two major Aurora kinases carry out critical functions at distinct mitotic stages. Selective
inhibitors of these kinases, as well as pan-Aurora inhibitors, show antitumor efficacy and are …

[HTML][HTML] How and when to end the COVID-19 lockdown: an optimization approach

T Rawson, T Brewer, D Veltcheva… - Frontiers in Public …, 2020 - frontiersin.org
Countries around the world are in a state of lockdown to help limit the spread of SARS-CoV-2.
However, as the number of new daily confirmed cases begins to decrease, governments …

Discovery of potent and selective pyrazolopyrimidine janus kinase 2 inhibitors

…, C Morris, J Murray, RM Pastor, T Rawson… - Journal of medicinal …, 2012 - ACS Publications
The discovery of somatic Jak2 mutations in patients with chronic myeloproliferative neoplasms
has led to significant interest in discovering selective Jak2 inhibitors for use in treating …

Author Correction: Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England

PN Perez-Guzman, E Knock, N Imai, T Rawson… - nature …, 2023 - nature.com
The code linked in the Code availability statement in the Article is correct: https://github. com/mrc-ide/sarscov2-severity-england.
The previous incorrect version of the code is available at…

Potent α4β1 peptide antagonists as potential anti-inflammatory agents

DY Jackson, C Quan, DR Artis, T Rawson… - Journal of medicinal …, 1997 - ACS Publications
The migration, adhesion, and subsequent extravasation of leukocytes into inflamed tissues
contribute to the pathogenesis of a variety of inflammatory diseases including asthma, …

Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study

N Imai, T Rawson, ES Knock, R Sonabend… - The Lancet Public …, 2023 - thelancet.com
Background The UK was the first country to start national COVID-19 vaccination programmes,
initially administering doses 3 weeks apart. However, early evidence of high vaccine …

From peptide to non-peptide. 2. The de novo design of potent, non-peptidal inhibitors of platelet aggregation based on a benzodiazepinedione scaffold

…, TR Gadek, LR McGee, T Rawson… - Journal of the …, 1994 - ACS Publications
Earlier studies of peptides containing the arginine-glycine-aspartic acid (RGD) sequence
led to the development of a structural model describing the three-dimensional presentation …

A pentacyclic aurora kinase inhibitor (AKI-001) with high in vivo potency and oral bioavailability

TE Rawson, M Rüth, E Blackwood… - Journal of medicinal …, 2008 - ACS Publications
Aurora kinase inhibitors have attracted a great deal of interest as a new class of antimitotic
agents. We report a novel class of Aurora inhibitors based on a pentacyclic scaffold. A …